Bulk Manufacturer Registration Application: Royal Emerald Pharmaceuticals for Controlled Substances
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
Royal Emerald Pharmaceuticals has submitted a formal application to the U.S. Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of one or more basic classes of controlled substances. This type of registration is required under the Controlled Substances Act (CSA) for any entity seeking to produce controlled substances at a commercial or research scale in the United States. The DEA publishes such notices in the Federal Register to fulfill its statutory obligation to provide public notice and an opportunity for comment before granting manufacturing registrations. Interested parties, including competitors, public health advocates, and law enforcement entities, may file comments or objections within the designated period. Bulk manufacturers of controlled substances play a critical role in the pharmaceutical supply chain, producing active pharmaceutical ingredients (APIs) that are later formulated into finished drug products. Registration approval is contingent on DEA review of the applicant's security measures, record-keeping practices, and compliance history. The specific controlled substance class(es) covered by this application are referenced in the supplementary information section of the original Federal Register notice, which details the Schedule and drug category involved.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Royal Emerald Pharmaceuticals has formally applied for DEA bulk manufacturer registration as of April 1, 2026
- Application covers one or more basic classes of controlled substances (specific schedules referenced in supplementary Federal Register content)
- Public notice period opened, allowing interested parties to file comments or objections with the DEA
+ 2 more changes with Pro
Obligations
What this law requires
Submit formal bulk manufacturer registration application to the DEA for each controlled substance class intended to be produced
Implement and maintain security measures adequate to prevent theft or diversion of controlled substances
Establish and maintain record-keeping practices documenting production, inventory, and distribution of controlled substances
Demonstrate compliance history and absence of disqualifying violations prior to registration approval
Allow DEA to review and evaluate applicant's security measures, record-keeping practices, and compliance history before granting registration